Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countriesAna da Silva Filipe, Emma C. Thomson, Vattipally B. Sreenu et al.|Journal of Hepatology|2017Cited by 34
Peer support for people living with hepatitis B virus—A foundation for treatment expansionLouise Downs, Stuart Flanagan, Robert Newton et al.|Journal of Viral Hepatitis|2024Cited by 19
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UKVictoria Hamill, Hamish Innes, Will Gelson et al.|Liver International|2023Cited by 17
Reply to: “Reply to: ‘Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries’”Ana da Silva Filipe, Emma C. Thomson, Vattipally B. Sreenu et al.|Journal of Hepatology|2018Cited by 2